504 related articles for article (PubMed ID: 25449638)
1. Two-year outcome of repeat trabeculectomy with mitomycin C in primary open-angle and PEX glaucoma.
Meyer LM; Graf NE; Philipp S; Fischer MT; Haller K; Distelmaier P; Schönfeld CL
Eur J Ophthalmol; 2015; 25(3):185-91. PubMed ID: 25449638
[TBL] [Abstract][Full Text] [Related]
2. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
3. Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Lim SH; Cha SC
J Glaucoma; 2017 Apr; 26(4):303-310. PubMed ID: 26709498
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Panarelli JF; Banitt MR; Gedde SJ; Shi W; Schiffman JC; Feuer WJ
Ophthalmology; 2016 Apr; 123(4):789-95. PubMed ID: 26746596
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Brüggemann A; Despouy JT; Wegent A; Müller M
J Glaucoma; 2013 Sep; 22(7):577-83. PubMed ID: 23632395
[TBL] [Abstract][Full Text] [Related]
7. Same-site Trabeculectomy Revision for Failed Trabeculectomy: Outcomes and Risk Factors for Failure.
Hirunpatravong P; Reza A; Romero P; Kim EA; Nouri-Mahdavi K; Law SK; Morales E; Caprioli J
Am J Ophthalmol; 2016 Oct; 170():110-118. PubMed ID: 27491696
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma.
Law SK; Shih K; Tran DH; Coleman AL; Caprioli J
Am J Ophthalmol; 2009 Nov; 148(5):685-695.e1. PubMed ID: 19596220
[TBL] [Abstract][Full Text] [Related]
9. Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Koh V; Chen D; Aquino CM; Aduan J; Sng C; Chee LS; Chew P
Jpn J Ophthalmol; 2017 May; 61(3):245-252. PubMed ID: 28188405
[TBL] [Abstract][Full Text] [Related]
10. Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.
Takihara Y; Inatani M; Ogata-Iwao M; Kawai M; Inoue T; Iwao K; Tanihara H
JAMA Ophthalmol; 2014 Jan; 132(1):69-76. PubMed ID: 24232829
[TBL] [Abstract][Full Text] [Related]
11. Smaller-incision Revision of Trabeculectomy With Mitomycin: Long-term Outcomes and Complications.
Chen PP; Moeller KL
J Glaucoma; 2019 Jan; 28(1):27-31. PubMed ID: 30394979
[TBL] [Abstract][Full Text] [Related]
12. Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.
Supawavej C; Nouri-Mahdavi K; Law SK; Caprioli J
J Glaucoma; 2013 Jan; 22(1):52-9. PubMed ID: 21623217
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial.
Pakravan M; Esfandiari H; Yazdani S; Douzandeh A; Amouhashemi N; Yaseri M; Pakravan P
Br J Ophthalmol; 2017 Sep; 101(9):1275-1280. PubMed ID: 28100482
[TBL] [Abstract][Full Text] [Related]
14. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
15. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Vahedian Z; Mafi M; Fakhraie G; Zarei R; Eslami Y; Ghadimi H; Mohebbi M
J Glaucoma; 2017 Sep; 26(9):829-834. PubMed ID: 28777224
[TBL] [Abstract][Full Text] [Related]
16. Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis-Related Uveitic Glaucoma: A Retrospective Analysis.
Leinonen S; Kotaniemi K; Kivelä T; Majander A
JAMA Ophthalmol; 2015 Nov; 133(11):1323-8. PubMed ID: 26402863
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
18. The size of subconjunctival preparation does not influence the outcome of trabeculectomy with mitomycin C.
Wasielica-Poslednik J; Hoffmann EM; Herzog D; Aliyeva S; Lamparter J; Pfeiffer N
J Glaucoma; 2015; 24(5):e75-9. PubMed ID: 25304277
[TBL] [Abstract][Full Text] [Related]
19. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Surgical Outcomes Between Phacocanaloplasty and Phacotrabeculectomy at 12 Months' Follow-up: A Longitudinal Cohort Study.
Schoenberg ED; Chaudhry AL; Chod R; Zurakowski D; Ayyala RS
J Glaucoma; 2015 Sep; 24(7):543-9. PubMed ID: 24240873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
